Rating History for Maze Therapeutics (MAZE) by Wells Fargo

More Stocks Rated by Wells Fargo | Latest Ratings for MAZE
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/4/2025 Sadia Rahman New Coverage Overweight
(N/A)		 55.00
(N/A)		 37.27
(44.83)		 20.28% Details